Companies › ENTX

Entera Bio Ltd (ENTX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001638097 · EDGAR filings · Updated 2026-07-28

Entera Bio Ltd (ENTX) has reported institutional ownership of 16.9%, with 26 institutional managers holding positions valued at $8.68M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-28 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-16 — Current report (8-K) filed
• 2026-07-16 — Insider transaction reported (Form 4)
• 2026-06-03 — DEFA14A filed
• 2026-06-03 — ARS filed
• 2026-06-03 — Proxy statement (DEF 14A) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Entera Bio Ltd has 26 institutional holders and institutional ownership of 16.9%.

Insider activity

Insiders reported 19 transactions (8 buys, 0 sells) across 11 reporting insiders, with a net reported value of $140.9K.

Data flags from SEC filings

Related companies

CYTOSORBENTS CORP (CTSO) · ONEMEDNET CORP (ONMD) · CITIUS ONCOLOGY INC COM (CTOR) · IMMUCELL CORP (ICCC) · METAGENOMI THERAPEUTICS INC (MGX) · MYOMO INC (MYO)